TITLE

The effects of platelet inhibitors on blood use in cardiac surgery

AUTHOR(S)
Lee, Leonard Y; Debois, William; Krieger, Karl H; Girardi, Leonard N; Russo, Laura; McVey, James; Ko, Wilson; Altorki, Nasser K; Brodman, Richard A; Isom, O Wayne
PUB. DATE
January 2002
SOURCE
Perfusion;Jan2002, Vol. 17 Issue 1, p33
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Platelet inhibition via glycoprotein (GP) IIb/IIIa receptor antagonists has greatly reduced the need for emergent cardiac surgery. However, this change has come at a cost to both the patient and the cardiac surgical team in terms of increased bleeding risk. Current guidelines for patients requiring coronary artery bypass surgery include: 1) cessation of GP IIb/IIIa inhibitor; 2) delay of surgery for up to 12 h if abciximab, tirofiban, or eptafibitide is used; 3) utilization of ultrafiltration via zero balance technique; 4) maintenance of standard heparin dosing despite elevated bleeding times; and 5) transfusion of platelets as needed, rather than prophylactically. These agents present cardiac surgery teams with increased risk during CABG, although overall risk may be diminished by the substantial benefits to patients with acute coronary syndromes and percutaneous interventions, i.e., reduced infarction rates and improved vessel patency. With judicious planning, urgent coronary artery bypass can be safely performed on patients who have been treated with GP IIb/IIIa receptor inhibitors.
ACCESSION #
6567711

 

Related Articles

  • Coronary artery bypass surgery. Cameron, E.W.J.; Walker, W.S. // BMJ: British Medical Journal (International Edition);5/12/90, Vol. 300 Issue 6734, p1219 

    Focuses on the history of coronary artery bypass surgery in Great Britain. Cause of graft stenosis; Capability of dipyridamole and aspirin to reduce platelet adhesiveness; Comparison between warfarin and placebo.

  • Does Short-Term Pre-Operative Aspirin in Coronary Bypass Patients Increase Post-Operative Bleeding? Fuller, James K.; Copeland, Jack G. // Vascular Surgery;May/Jun1985, Vol. 19 Issue 3, p174 

    A prospective physician blinded study was undertaken to evaluate post-operative bleeding in coronary artery bypass patients treated with aspirin pre-operatively. Thirty patients were randomized: nine received no aspirin, eleven received 325 mg twelve hours pre-operatively, and ten received 650...

  • BAS/BSCR29 Apolipoprotein(a) impairs adaptive remodelling in human saphenous vein endothelial and smooth muscle cells. Riches, K.; Franklin, L.; Chowdhury, R.; Maqbool, A.; O'Regan, D. J.; Ball, S. G.; Koschinsky, M. L.; Turner, N. A.; Porter, K. E. // Heart;Sep2010, Vol. 96 Issue 17, pe20 

    Apolipoprotein(a) (apo(a)), a unique glycoprotein component of plasma lipoprotein(a) (Lp(a)),exhibits resistance to classical lipid-lowering treatments. Coronary artery bypass grafting (CABG) is commonly used to bypass coronary arteries diseased by atherosclerosis, routinely using the saphenous...

  • Relationship between elevated platelet volume and saphenous vein graft disease. Tavil, Yusuf; Şen, Nihat; Yazıcı, Hüseyin Uğur; Hızal, Fatma; Açıkgöz, Sadık Kadri; Turfan, Murat; Çengel, Atiye // Clinical & Investigative Medicine;Jun2010, Vol. 33 Issue 3, pE161 

    Background: Saphenous vein graft (SVG) disease is the major determinant of long term graft viability in patients undergoing coronary artery bypass graft (CABG) surgery. Although, platelets play a major role in this pathogenetic process the nature of this interaction has not been yet been...

  • Platelet Activation in Bypass Surgery for Critical Limb Ischemia. Mohan, Irwin V.; Mikhailidis, Dimitri P.; Stansby, Gerard P. // Vascular & Endovascular Surgery;Aug/Sep2007, Vol. 41 Issue 4, p322 

    Platelet activation contributes to graft occlusion after bypass surgery. This study investigated platelet activation status before, during, and after bypass. Blood was taken preoperatively from patients undergoing femoro-popliteal bypass and at incision, after dissection, after ischemia, after...

  • Quantitative and Temporal Differences in Coagulation, Fibrinolysis and Platelet Activation after On-Pump and Off-Pump Coronary Artery Bypass Surgery Vallely, Michael P.; Bannon, Paul G.; Bayfield, Matthew S.; Hughes, Clifford F.; Kritharides, Len // Heart, Lung & Circulation;Apr2009, Vol. 18 Issue 2, p123 

    Background: With the increasing use of OPCAB, potentially devastating thromboembolic events, including graft thrombosis may become increasingly evident. We present a study of the quantitative and temporal differences of the coagulation system, fibrinolysis and platelet activation after coronary...

  • Blood transfusion in coronary artery surgery: focus on modifiable risk factors. Petricevic, Mate; Biocina, Bojan; Habekovic, Renata; Milicic, Davor // European Journal of Cardio-Thoracic Surgery;Oct2013, Vol. 44 Issue 4, p775 

    The article discusses the higher risk of Red Blood Cell (RBC) transfusion in isolated coronary artery bypass grafting (CABG) as predicted by the study of De Santo LS and colleagues published in the Journal of Thrombosis and Thrombolysis. The topics discussed include eight predictive factors of...

  • Blood component utilization in cardiac revascularization in comparison of on-and off pump techniques in a tertiary care hospital of North India. Sonker, A.; Chaudhary, R.; Agarwal, S.; Pandey, S.; Khetan, D. // Asian Journal of Transfusion Science;Jul-Dec2007, Vol. 1 Issue 2, p97 

    Introduction: Cardiac revascularizations on a beating heart avoid the side effects of cardiopulmonary bypass (neurological injury and hemodilution and coagulopathy). We examined peri-operative use of blood components during coronary artery bypass grafting using either on-pump or off-pump...

  • Sodium alginate/heparin composites on PVC surfaces inhibit the thrombosis and platelet adhesion: applications in cardiac surgery. Wenqing Gao; Tingting Lin; Tong Li; Meili Yu; Xiaomin Hu; Dawei Duan // International Journal of Clinical & Experimental Medicine;2013, Vol. 6 Issue 4, p259 

    Thrombosis and hemocyte damage are the main problems of applied non-coated biomaterials to cardiac surgery that remain unsolved. The present study is aimed at the chemical modification of polyvinyl chloride (PVC) for applications in cardiac surgery and the biological property assessment of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics